Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Workers' Comp
White Paper
A Comprehensive Guide to Texas Health Care Networks (HCNs)
Workers' Comp
Article
Predictive Power: How AI Is Helping Workers' Comp Insurers Stay Ahead of Demographic Shifts
America's shifting workforce demographics, combined with health care policy changes, are fundamentally altering workers' compensation risk profiles
Workers' Comp
Case Study
How to Go from High-Dollar to High-Value: Five Strategies for Claims Cost Control
Risk & Insurance
In the News
Opioid Use Drops While Specialty Drug Costs Surge in Workers’ Compensation
Workers' Comp
Article
Ask The Pharmacist: Pain Pumps in Workers’ Compensation
How do PCA pumps support pain management, reduce costs and speed recovery for injured employees? For adjusters, understanding the too
Workers' Comp
Article
Functional Restoration Programs: What the Latest CWCI Study Reveals, and Why Oversight Matters
The California Workers’ Compensation Institute (CWCI) recently released a study exami